Marshall Edwards is an oncology company specializing in the clinical development of novel therapeutics that target cancer metabolism. Marshall Edwards’ lead drug candidates are ME-143 and ME-344, which have been shown to interact with certain enzyme targets to inhibit tumor cell metabolism – a function that is critical for cancer cell survival. For more information visit the company’s Web site at www.marshalledwardsinc.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below: